BIOLIGH was IPO since 2011 and is currently trading in the SHENZHEN STOCK EXCHANGE. Founded in 1993, BIOLIGHT is an internationally established leading provider in medical devices, medical consumables and healthcare solutions. At BIOLIGHT, we look beyond the technology to the experience of dedicated healthcare professionals and find inspirations in the needs of our customers. That is why BIOLIGHT has continued to be considered as a leading innovator in the areas of patient monitoring and emergency responds, Hemodialysis renal care, and digital health homecare solutions. Biolight, with headquarter in Zhuhai China, has a firm global RND, Marketing, Sales and Service presents. Biolight has established 8 researches and manufacturing plants, 12 subsidiaries, and oversea sales branches covering sales and services in Asia, Africa, Europe, North America, and Latin America expanding over 135 countries and counting.BIOLIGHT established 7 high-techs manufacturing campus across China with a combine area of 1,898,000 sqm conveniently and efficiently deliver quality products across the country and across the globe. BIOLIGHT maintains many long term relationships with top universities, global health organizations, health and social responsibility organizations actively involves in educations, humanitarian mission, and patient care social projects. Fulfilling corporate social responsibility is one of our core missions at BIOLIGHT. As an integral part of global economic ecosystem, BIOLIGHT has made constant effort to contribute to public welfare in China and across, focusing largely in: access to education, access to technology, public health, and sustaining communities. BIOLIGHT will continue to maximize the impact of our corporate responsibility programs by leveraging our unique company resource in biomedical engineering and digital health creating a platform to better focusing on generating values for our society.